Search
for
Sort by
Research 121–150 of 1000+
- Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double‐blinded clinical trial
- Porphyrinoid Photosensitizers for Targeted and Precise Photodynamic Therapy: Progress in Fabrication
- Ethno-medico-botanical claims of Bondla wildlife sanctuary vicinity of Goa
- Regeneration, Wound Healing and Cancer
- Histomorphological Study of Nail Changes in Various Dermatoses — An Understudied Entity in Dermatopathology
- Clear cell variant of eccrine porocarcinoma of the hand: A case report
- P62 Drug induced hypothyroidism in patients receiving treatment for multi-drug resistant tuberculosis
- Histomorphological features of the skin in neonate rabbits
- Histomorphological, Histochemical and Histoenzymic Studies on the Dermis of Skin of Goat (Capra hircus)
- Histological and immunohistochemical examination of the effect of the nonsteroidal antiandrogen {flutamide} on some organs of the male reproductive system in albino rats
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Holistic Ayurvedic Management of Psoriasis with special reference to Eka Kustha
- Fluticasone Propionate-loaded Black Cumin Oil NLCs with Dual Deposition/Permeation Capabilities for Enhanced Psoriasis Management
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- MANAGEMENT OF EKAKUSTHA (PLAQUE PSORIASIS) THROUGH INTEGRATED SHODHANA AND SHAMANA CHIKITSA: A SINGLE CASE STUDY
- MANAGEMENT OF EKAKUSTHA (PLAQUE PSORIASIS) THROUGH INTEGRATED SHODHANA AND SHAMANA CHIKITSA: A SINGLE CASE STUDY
- Exploration of Cosmetic Haircare Practices among Indigenous Women of Nandurbar District
- EFFECTIVENESS OF BAKUCHI (PSORALEA CORYLIFOLIA LINN.) AS RASAYANA THERAPY IN PSORIASIS - A CASE REPORT
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- Enhancement of drug permeation across skin through stratum corneum ablation
- Finding Long-COVID: Temporal Topic Modeling of Electronic Health Records from the N3C and RECOVER Programs
- 44047 Long Term Real-World Treat-to-Target Skin Clearance and Maintenance of Response with Risankizumab in Patients with Moderate to Severe Psoriasis From the CorEvitas Psoriasis Registry
- New Topical Treatment for Psoriasis
- 176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice
- Dermpath & Clinic: Telangiectasia macularis eruptiva perstans
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- Immune signatures of psoriasis: Comparison of genetic expression profiles in psoriasis patients after therapy with biologic agents